These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29530207)

  • 1. Initiation and maintenance of statins and aspirin after acute coronary syndromes (ANZACS-QI 11).
    Kerr AJ; Turaga M; Grey C; Lee M; McLachlan A; Devlin G
    J Prim Health Care; 2016 Sep; 8(3):238-249. PubMed ID: 29530207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic differences in the initiation and maintenance of statins in the first year post ACS in New Zealand: a data linkage study (ANZACS-QI 57).
    Muniandy A; Lee M; Grey C; Ferrier K; Kerr AJ
    N Z Med J; 2021 Apr; 134(1534):31-45. PubMed ID: 33927436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2).
    Grey C; Jackson R; Wells S; Thornley S; Marshall R; Crengle S; Harrison J; Riddell T; Kerr A
    Heart; 2014 May; 100(10):770-4. PubMed ID: 24436219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilisation and maintenance of high-intensity statins following acute coronary syndrome and coronary angiography: opportunities to improve care (ANZACS-QI 26).
    Kerr AJ; Mitnala S; Lee M; White HD
    N Z Med J; 2020 Mar; 133(1511):21-40. PubMed ID: 32161419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the Statin Possession Ratio Cut-Off Which Identifies Those at Increased Risk Following Acute Coronary Syndrome (ANZACS-QI 68)?
    Ali M; Kerr AJ; Lee M; Chan DZL
    Heart Lung Circ; 2023 Apr; 32(4):487-496. PubMed ID: 36641263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of capture of coronary intervention and associated acute coronary syndromes in the all New Zealand acute coronary syndrome quality improvement cardiac registry and excellent agreement with national administrative datasets (ANZACS-QI 25).
    Kerr AJ; Lee M; Jiang Y; Grey C; Wells S; Williams M; Jackson R; Poppe K
    N Z Med J; 2019 Mar; 132(1492):19-29. PubMed ID: 30921308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide dispensing of cardioprotective medications during the first year following acute coronary syndrome (ANZACS-QI 56).
    Butchard M; Kerr AJ; Grey C; Wu B; Hider P
    N Z Med J; 2021 Mar; 134(1531):36-54. PubMed ID: 33767486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and Long-Term Outcome of Acute Coronary Syndrome Patients Presenting with Heart Failure in a Contemporary New Zealand Cohort (ANZACS-QI 4).
    Kueh SH; Devlin G; Lee M; Doughty RN; Kerr AJ
    Heart Lung Circ; 2016 Aug; 25(8):837-46. PubMed ID: 27132622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1).
    Kerr A; Exeter D; Hanham G; Grey C; Zhao J; Riddell T; Lee M; Jackson R; Wells S
    N Z Med J; 2014 Aug; 127(1400):39-69. PubMed ID: 25145366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Burden of Risk Factors Among Patients With Early Onset Acute Coronary Syndromes: The ANZACS-QI New Zealand National Cohort (ANZACS-QI 17).
    Earle NJ; Poppe KK; Doughty RN; Rolleston A; Kerr AJ; Legget ME
    Heart Lung Circ; 2018 May; 27(5):568-575. PubMed ID: 28606608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event.
    Thornley S; Marshall R; Chan WC; Kerr A; Harrison J; Jackson G; Crengle S; Wright C; Wells S; Jackson R
    Eur J Prev Cardiol; 2012 Jun; 19(3):349-57. PubMed ID: 21450568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Risk Model to Predict Statin Non-Adherence Following an Acute Coronary Syndrome.
    Liao YB; Lee M; Poppe KK; Kerr AJ; Stewart RAH
    Heart Lung Circ; 2023 May; 32(5):612-618. PubMed ID: 36933980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and type of bleeding complications early and late after acute coronary syndrome admission in a New Zealand cohort (ANZACS-QI-7).
    Voss WB; Lee M; Devlin GP; Kerr AJ
    N Z Med J; 2016 Jul; 129(1437):27-38. PubMed ID: 27362596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9).
    Kerr A; Williams MJ; White H; Doughty R; Nunn C; Devlin G; Grey C; Lee M; Flynn C; Rhodes M; Sutherland K; Wells S; Jackson R; Stewart R
    N Z Med J; 2016 Aug; 129(1439):23-36. PubMed ID: 27507719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnicity and revascularisation following acute coronary syndromes: a 5-year cohort study (ANZACS-QI-3).
    Kerr AJ; Mustafa A; Lee M; Wells S; Grey C; Riddell T; Harrison W
    N Z Med J; 2014 May; 127(1393):38-51. PubMed ID: 24816955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic Differences in Coronary Revascularisation following an Acute Coronary Syndrome in New Zealand: A National Data-linkage Study (ANZACS-QI 12).
    Grey C; Jackson R; Wells S; Randall D; Harwood M; Mehta S; Exeter DJ; Kerr AJ
    Heart Lung Circ; 2016 Aug; 25(8):820-8. PubMed ID: 27118265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
    Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
    Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Economic Evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry Program (ANZACS-QI 28).
    Lee P; Zomer E; Liew D
    Heart Lung Circ; 2020 Jul; 29(7):1046-1053. PubMed ID: 31537440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An economic evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry programme-subanalyses for Māori (ANZACS-QI 42).
    Lee P; Zomer E; Liew D
    N Z Med J; 2020 May; 133(1514):16-32. PubMed ID: 32379736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.